High Risk Popurations among COPD Patients in Japan

Trial Identifier: D589BR00033
Sponsor: AstraZeneca
NCTID:: NCT02413359
Start Date: May 2015
Primary Completion Date: July 2015
Study Completion Date: July 2015
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan, Hyougo Takarazuka, Hyougo, Japan, 885-0845